$LFT
Lument Finance Trust, Inc.

2024 Q3 Form 10-Q Financial Statement

#000162828024036809 Filed on August 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $29.67M $30.64M
YoY Change -6.87% 35.29%
Cost Of Revenue $21.31M $22.93M
YoY Change -4.47% 51.47%
Gross Profit $8.358M $7.710M
YoY Change -12.39% 2.68%
Gross Profit Margin 28.17% 25.16%
Selling, General & Admin $1.690M $1.700M
YoY Change -25.87% -35.01%
% of Gross Profit 20.22% 22.04%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $2.088M $3.121M
YoY Change -35.57% -37.34%
Operating Profit $6.270M $4.589M
YoY Change -0.48% 81.48%
Interest Expense -$46.02K -$10.27K
YoY Change -4990.48%
% of Operating Profit -0.73% -0.22%
Other Income/Expense, Net
YoY Change
Pretax Income $6.284M $4.597M
YoY Change -1.5% 78.58%
Income Tax $3.489K -$1.030K
% Of Pretax Income 0.06% -0.02%
Net Earnings $6.281M $4.598M
YoY Change -1.24% 78.63%
Net Earnings / Revenue 21.17% 15.01%
Basic Earnings Per Share $0.10 $0.07
Diluted Earnings Per Share $0.10 $0.07
COMMON SHARES
Basic Shares Outstanding 52.28M shares 52.26M shares
Diluted Shares Outstanding 52.28M shares 52.27M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $45.59M $65.14M
YoY Change 5.04% -33.87%
Cash & Equivalents $45.59M $65.14M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $52.41M $106.3M
YoY Change -36.93% 1.82%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $19.49M $1.457M
YoY Change 214.37% 14.39%
Total Long-Term Assets $1.204B $1.191B
YoY Change -11.52% 16.55%
TOTAL ASSETS
Total Short-Term Assets $52.41M $106.3M
Total Long-Term Assets $1.204B $1.191B
Total Assets $1.256B $1.297B
YoY Change -12.98% 15.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $3.153M $3.365M
YoY Change -17.02% 32.36%
Deferred Revenue
YoY Change
Short-Term Debt $955.1M $995.9M
YoY Change -16.61% 19.91%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $964.9M $1.007B
YoY Change -16.46% 20.01%
LONG-TERM LIABILITIES
Long-Term Debt $47.41M $47.34M
YoY Change 0.44% 0.53%
Other Long-Term Liabilities $528.0K $700.4K
YoY Change 32.01% -24.99%
Total Long-Term Liabilities $47.94M $48.04M
YoY Change 0.7% 0.03%
TOTAL LIABILITIES
Total Short-Term Liabilities $964.9M $1.007B
Total Long-Term Liabilities $47.94M $48.04M
Total Liabilities $1.013B $1.055B
YoY Change -15.79% 18.92%
SHAREHOLDERS EQUITY
Retained Earnings $65.23M $58.95M
YoY Change 54.0% 63.76%
Common Stock $522.9K $522.8K
YoY Change 0.12% 0.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $243.0M $242.1M
YoY Change
Total Liabilities & Shareholders Equity $1.256B $1.297B
YoY Change -12.98% 15.18%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $6.281M $4.598M
YoY Change -1.24% 78.63%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $6.229M $5.514M
YoY Change 14.93% 29.86%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $39.31M $82.18M
YoY Change -110.77% -12323.16%
Cash From Investing Activities $39.31M $82.18M
YoY Change -110.77% -12323.16%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -47.06M -85.75M
YoY Change -115.2% 1883.65%
NET CHANGE
Cash From Operating Activities 6.229M 5.514M
Cash From Investing Activities 39.31M 82.18M
Cash From Financing Activities -47.06M -85.75M
Net Change In Cash -1.514M 1.947M
YoY Change -96.98% -359.86%
FREE CASH FLOW
Cash From Operating Activities $6.229M $5.514M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1874284 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
61586 usd
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
6980182 usd
CY2024Q1 us-gaap Dividends Common Stock
DividendsCommonStock
3658012 usd
CY2024Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1184999 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
242935302 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52266174 shares
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
4598446 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
2574227 usd
CY2024Q2 us-gaap Dividends Common Stock
DividendsCommonStock
4182019 usd
CY2023Q2 us-gaap Dividends Common Stock
DividendsCommonStock
3133869 usd
CY2024Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1185001 usd
CY2023Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1185042 usd
CY2024Q2 us-gaap Dividends
Dividends
5367020 usd
CY2023Q2 us-gaap Dividends
Dividends
4318911 usd
CY2024Q2 us-gaap Undistributed Earnings
UndistributedEarnings
-768574 usd
CY2023Q2 us-gaap Undistributed Earnings
UndistributedEarnings
-1744684 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52226141 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
5011 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52266174 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52231152 shares
us-gaap Net Income Loss
NetIncomeLoss
11578628 usd
us-gaap Net Income Loss
NetIncomeLoss
8340918 usd
us-gaap Dividends Common Stock
DividendsCommonStock
7840030 usd
us-gaap Dividends Common Stock
DividendsCommonStock
6267738 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
2370000 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
2370000 usd
us-gaap Dividends
Dividends
10210030 usd
us-gaap Dividends
Dividends
8637738 usd
us-gaap Undistributed Earnings
UndistributedEarnings
1368598 usd
us-gaap Undistributed Earnings
UndistributedEarnings
-296820 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52257737 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52225649 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
5503 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52257737 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52231152 shares
CY2024Q2 oaks Paydown Receivable
PaydownReceivable
33360000 usd
CY2023Q4 oaks Paydown Receivable
PaydownReceivable
0 usd
CY2024Q2 us-gaap Other Assets
OtherAssets
1906206 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
2253280 usd
CY2024Q2 us-gaap Assets
Assets
1296959416 usd
CY2023Q4 us-gaap Assets
Assets
1446932447 usd
CY2024Q2 oaks Collateralized Loan Obligations And Secured Financing Net
CollateralizedLoanObligationsAndSecuredFinancingNet
995895094 usd
CY2023Q4 oaks Collateralized Loan Obligations And Secured Financing Net
CollateralizedLoanObligationsAndSecuredFinancingNet
1146210752 usd
CY2024Q2 us-gaap Secured Long Term Debt
SecuredLongTermDebt
47344478 usd
CY2024Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
3364878 usd
CY2023Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
4092701 usd
CY2024Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
5179519 usd
CY2023Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
4654904 usd
CY2024Q2 oaks Management Fees And Expenses Payable
ManagementFeesAndExpensesPayable
2280000 usd
CY2023Q4 oaks Management Fees And Expenses Payable
ManagementFeesAndExpensesPayable
1587875 usd
CY2024Q2 us-gaap Other Liabilities
OtherLiabilities
700421 usd
CY2024Q2 us-gaap Liabilities
Liabilities
1054764390 usd
CY2023Q4 us-gaap Liabilities
Liabilities
1206140067 usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.07875
us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.07875
CY2024Q2 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
60000000 usd
CY2023Q4 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
60000000 usd
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2400000 shares
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
57254935 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
57254935 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
52248631 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
522753 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
522487 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
314621082 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
314587299 usd
CY2024Q2 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
189255780 usd
CY2023Q4 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
179045749 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
58952536 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
47373908 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
242095526 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
240692880 usd
CY2024Q2 us-gaap Minority Interest
MinorityInterest
99500 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
99500 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
240792380 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1296959416 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1446932447 usd
us-gaap Interest And Fee Income Loans Commercial Real Estate
InterestAndFeeIncomeLoansCommercialRealEstate
64627272 usd
us-gaap Interest And Fee Income Loans Commercial Real Estate
InterestAndFeeIncomeLoansCommercialRealEstate
43763269 usd
us-gaap Interest Income And Fees Bankers Acceptances Certificates Of Deposit And Commercial Paper
InterestIncomeAndFeesBankersAcceptancesCertificatesOfDepositAndCommercialPaper
1089108 usd
oaks Interest Expense Collateralized Loan Obligations And Secured Financings
InterestExpenseCollateralizedLoanObligationsAndSecuredFinancings
41690411 usd
oaks Interest Expense Collateralized Loan Obligations And Secured Financings
InterestExpenseCollateralizedLoanObligationsAndSecuredFinancings
27232907 usd
oaks Interest Expense Secured Term Loan
InterestExpenseSecuredTermLoan
1874421 usd
oaks Interest Expense Secured Term Loan
InterestExpenseSecuredTermLoan
1864122 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
22515484 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
15755348 usd
oaks Management And Incentive Fees
ManagementAndIncentiveFees
4380948 usd
oaks Management And Incentive Fees
ManagementAndIncentiveFees
2180636 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2265084 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1830789 usd
oaks Reimbursable Operating Expense
ReimbursableOperatingExpense
875074 usd
oaks Reimbursable Operating Expense
ReimbursableOperatingExpense
1087652 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-57938 usd
CY2024Q2 us-gaap Share Based Compensation
ShareBasedCompensation
163750 usd
us-gaap Share Based Compensation
ShareBasedCompensation
222500 usd
us-gaap Share Based Compensation
ShareBasedCompensation
123694 usd
us-gaap Noninterest Expense
NoninterestExpense
7801544 usd
us-gaap Noninterest Expense
NoninterestExpense
7097055 usd
oaks Unrealized Gain Loss On Mortgage Service Rights
UnrealizedGainLossOnMortgageServiceRights
-5647 usd
oaks Unrealized Gain Loss On Mortgage Service Rights
UnrealizedGainLossOnMortgageServiceRights
-48923 usd
us-gaap Fees And Commissions Mortgage Banking And Servicing
FeesAndCommissionsMortgageBankingAndServicing
56773 usd
us-gaap Fees And Commissions Mortgage Banking And Servicing
FeesAndCommissionsMortgageBankingAndServicing
96924 usd
oaks Other Noninterest Income Loss
OtherNoninterestIncomeLoss
-3125450 usd
oaks Other Noninterest Income Loss
OtherNoninterestIncomeLoss
-327398 usd
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
11588490 usd
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
8330895 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9862 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-10023 usd
us-gaap Net Income Loss
NetIncomeLoss
11578628 usd
us-gaap Net Income Loss
NetIncomeLoss
8340918 usd
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
2370000 usd
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
2370000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
5970918 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1389185 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
1389185 usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52257737 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52231152 shares
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
240792380 usd
us-gaap Interest Income And Fees Bankers Acceptances Certificates Of Deposit And Commercial Paper
InterestIncomeAndFeesBankersAcceptancesCertificatesOfDepositAndCommercialPaper
1453044 usd
CY2023Q4 us-gaap Other Liabilities
OtherLiabilities
2373609 usd
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2400000 shares
CY2022 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2024#AccountingStandardsUpdate201613Member
CY2023Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
47220226 usd
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2400000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
52248631 shares
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
242195026 usd
oaks Financing Receivable Excluding Accrued Interest Including Loss On Unfunded Loan Commitments Expense Reversal
FinancingReceivableExcludingAccruedInterestIncludingLossOnUnfundedLoanCommitmentsExpenseReversal
3176576 usd
oaks Financing Receivable Excluding Accrued Interest Including Loss On Unfunded Loan Commitments Expense Reversal
FinancingReceivableExcludingAccruedInterestIncludingLossOnUnfundedLoanCommitmentsExpenseReversal
375399 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
9208628 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
9208628 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
5970918 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
5970918 usd
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
19947 usd
CY2024Q1 oaks Cost Of Issuing Of Common Stock Values
CostOfIssuingOfCommonStockValues
14196 usd
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
42494 usd
CY2024Q2 oaks Cost Of Issuing Of Common Stock Values
CostOfIssuingOfCommonStockValues
14196 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
4598446 usd
CY2024Q2 us-gaap Dividends Common Stock
DividendsCommonStock
4182019 usd
CY2024Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1185001 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
242195026 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
243001497 usd
CY2023Q1 oaks Cost Of Issuing Of Common Stock Values
CostOfIssuingOfCommonStockValues
14040 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
3358 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
5766691 usd
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
3133869 usd
CY2023Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1184958 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
240847239 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
13620 usd
CY2023Q2 oaks Cost Of Issuing Of Common Stock Values
CostOfIssuingOfCommonStockValues
14196 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
-10784 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
2574227 usd
CY2023Q2 us-gaap Dividends Common Stock
DividendsCommonStock
3133869 usd
CY2023Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1185042 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
239091195 usd
us-gaap Net Income Loss
NetIncomeLoss
11578628 usd
us-gaap Net Income Loss
NetIncomeLoss
8340918 usd
oaks Accretion Of Discounts On Held For Investment Loans
AccretionOfDiscountsOnHeldForInvestmentLoans
1423822 usd
oaks Accretion Of Discounts On Held For Investment Loans
AccretionOfDiscountsOnHeldForInvestmentLoans
1196 usd
oaks Amortization Of Premiums On Held For Investment Loans
AmortizationOfPremiumsOnHeldForInvestmentLoans
0 usd
oaks Amortization Of Premiums On Held For Investment Loans
AmortizationOfPremiumsOnHeldForInvestmentLoans
10687 usd
us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
114645 usd
us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
129300 usd
oaks Amortization Of Offering Costs
AmortizationOfOfferingCosts
-28392 usd
oaks Amortization Of Offering Costs
AmortizationOfOfferingCosts
-28236 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1891575 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1377153 usd
us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
3134168 usd
us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
375399 usd
oaks Unrealized Gain Loss On Mortgage Service Rights
UnrealizedGainLossOnMortgageServiceRights
-5647 usd
oaks Unrealized Gain Loss On Mortgage Service Rights
UnrealizedGainLossOnMortgageServiceRights
-48923 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
62442 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6194 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-827666 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
67811 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-347074 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
374179 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-727824 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
181405 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
692125 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
53917 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1673188 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
293818 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
14571454 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
10087692 usd
us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
0 usd
us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
72630053 usd
us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
162272158 usd
us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
123583470 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
162272158 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
50953417 usd
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
152082981 usd
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
0 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
7315416 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
6267738 usd
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
2370000 usd
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
2370000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-161768397 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-8637738 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
15075215 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
52403371 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
51517192 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47366365 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
66592407 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
99769736 usd
us-gaap Interest Paid Net
InterestPaidNet
42401080 usd
us-gaap Interest Paid Net
InterestPaidNet
27538470 usd
oaks Dividends Declared Not Yet Paid
DividendsDeclaredNotYetPaid
5179519 usd
oaks Dividends Declared Not Yet Paid
DividendsDeclaredNotYetPaid
4315119 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The financial statements have been prepared on the accrual basis of accounting in accordance with GAAP. The preparation of financial statements in conformity with GAAP requires the Company to make a number of significant estimates. These include estimates of fair value of certain assets and liabilities, amount and timing of credit losses, prepayment rates, and other estimates that affect the reported amounts of certain assets and liabilities as of the date of the financial statements and the reported amounts of certain revenues and expenses during the reported period. It is likely that changes in these estimates (e.g. valuation changes due to supply and demand, credit performance, prepayments, interest rates, or other reasons) will occur in the near term. The Company's estimates are inherently subjective in nature and actual results could differ from its estimates and the differences may be material.</span></div>
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
65135065 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
51247063 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
66592407 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
51517192 usd
CY2024Q2 oaks Number Of Commercial Real Estate Loans Included In Loan Performance Analytical Model
NumberOfCommercialRealEstateLoansIncludedInLoanPerformanceAnalyticalModel
125000 loan
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
1076148186 usd
CY2022Q4 us-gaap Allowance For Loan And Lease Losses Real Estate
AllowanceForLoanAndLeaseLossesRealEstate
4258668 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
1071889518 usd
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
583989 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
31250852 usd
CY2024Q2 oaks Number Of Sub Servers
NumberOfSubServers
2 sub-servicer
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
52275230 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
52275230 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
52248631 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
52248631 shares
CY2015Q4 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
10000000 usd
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
9193174 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
6059006 usd
CY2023Q4 oaks One Month Sofr Rate
OneMonthSOFRRate
0.0533
CY2024Q2 oaks One Month Sofr Rate
OneMonthSOFRRate
0.0533
CY2024Q2 oaks Weighted Average Libor Floor Rate
WeightedAverageLIBORFloorRate
0.0042
CY2023Q4 oaks Weighted Average Libor Floor Rate
WeightedAverageLIBORFloorRate
0.0038
CY2024Q2 oaks Weighted Average Floating Rate
WeightedAverageFloatingRate
1.000
CY2023Q4 oaks Weighted Average Floating Rate
WeightedAverageFloatingRate
1.000
CY2024Q2 oaks Average Risk Rate
AverageRiskRate
3.6
CY2023Q4 oaks Average Risk Rate
AverageRiskRate
3.5
CY2024Q2 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
9193174 usd
CY2024Q2 oaks Financing Receivable Allowance For Credit Loss Excluding Accrued Interest Unfunded Loan Commitments
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestUnfundedLoanCommitments
86055 usd
CY2024Q2 oaks Financing Receivable Allowance For Credit Loss Excluding Accrued Interest Including Unfunded Loan Commitments
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestIncludingUnfundedLoanCommitments
9279229 usd
CY2024Q2 oaks Financing Receivable Excluding Accrued Interest Net Of Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestNetOfAllowanceForCreditLoss
1201753001 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
6059006 usd
CY2023Q4 oaks Financing Receivable Allowance For Credit Loss Excluding Accrued Interest Unfunded Loan Commitments
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestUnfundedLoanCommitments
43647 usd
CY2023Q4 oaks Financing Receivable Allowance For Credit Loss Excluding Accrued Interest Including Unfunded Loan Commitments
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestIncludingUnfundedLoanCommitments
6102653 usd
CY2023Q4 oaks Financing Receivable Excluding Accrued Interest Net Of Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestNetOfAllowanceForCreditLoss
1397385160 usd
us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Period Increase Decrease
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease
1400000 usd
CY2024Q2 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
9200000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
6000000 usd
CY2022 oaks Reserve For Impaired Loan
ReserveForImpairedLoan
4300000 usd
CY2023Q2 oaks Reserve For Impaired Loan
ReserveForImpairedLoan
4300000 usd
CY2021Q2 oaks Number Of Newly Formed Subsidiaries
NumberOfNewlyFormedSubsidiaries
2 subsidiary
CY2021Q2 oaks Variable Interest Entity Qualitative And Quantitative Information Equity Interest
VariableInterestEntityQualitativeAndQuantitativeInformationEquityInterest
96250000 usd
CY2021Q2 oaks Proceeds From Issuance Of Debt Securities Allocated To Acquire Additional Loan Obligations
ProceedsFromIssuanceOfDebtSecuritiesAllocatedToAcquireAdditionalLoanObligations
330300000 usd
CY2021Q2 oaks Period To Acquire Additional Loan Obligations From Closing Date
PeriodToAcquireAdditionalLoanObligationsFromClosingDate
P180D
CY2021Q2 oaks Collateralized Loan Obligation Leverage Ratio
CollateralizedLoanObligationLeverageRatio
0.83
CY2023Q3 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.0314
CY2023Q3 oaks Debt Weighted Average Excluding Fees And Transaction Costs Term
DebtWeightedAverageExcludingFeesAndTransactionCostsTerm
P30D
CY2023Q4 oaks One Month Sofr Rate
OneMonthSOFRRate
0.0533
CY2024Q2 oaks One Month Sofr Rate
OneMonthSOFRRate
0.0533
CY2024Q2 oaks Weighted Average Libor Floor Rate Collateralized Loan Obligations
WeightedAverageLIBORFloorRateCollateralizedLoanObligations
0.0042
CY2023Q4 oaks Weighted Average Libor Floor Rate Collateralized Loan Obligations
WeightedAverageLIBORFloorRateCollateralizedLoanObligations
0.0038
CY2024Q2 oaks Financing Receivable Sofr Spread Rate
FinancingReceivableSOFRSpreadRate
0.0359
CY2023Q4 oaks Financing Receivable Sofr Spread Rate
FinancingReceivableSOFRSpreadRate
0.0354
us-gaap Loans Receivable Basis Spread On Variable Rate During Period
LoansReceivableBasisSpreadOnVariableRateDuringPeriod
0.0210
CY2023 us-gaap Loans Receivable Basis Spread On Variable Rate During Period
LoansReceivableBasisSpreadOnVariableRateDuringPeriod
0.0199
CY2019Q1 oaks Collateralized Loan Obligation Unamortized Discount
CollateralizedLoanObligationUnamortizedDiscount
39200000 usd
CY2024Q2 oaks Collateralized Loan Obligation Deferred Financing Costs
CollateralizedLoanObligationDeferredFinancingCosts
405522 usd
CY2023Q4 oaks Collateralized Loan Obligation Deferred Financing Costs
CollateralizedLoanObligationDeferredFinancingCosts
529774 usd
CY2024Q2 us-gaap Secured Debt
SecuredDebt
47750000 usd
CY2024Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
47750000 usd
CY2023Q4 us-gaap Secured Debt
SecuredDebt
47750000 usd
CY2023Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
47750000 usd
CY2024Q2 us-gaap Secured Debt
SecuredDebt
47750000 usd
CY2024Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
47750000 usd
CY2023Q4 us-gaap Secured Debt
SecuredDebt
47750000 usd
CY2023Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
47750000 usd
CY2024Q2 oaks Number Of Sub Servers
NumberOfSubServers
2 sub-servicer
CY2024Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
686325 usd
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
691973 usd
oaks Annual Management Fee Percentage
AnnualManagementFeePercentage
0.015
oaks Quarterly Management Fee Percentage
QuarterlyManagementFeePercentage
0.00375
CY2024Q2 oaks Reduction To Reimbursable Expenses As Percentage Of Waived Exit Fees Percent
ReductionToReimbursableExpensesAsPercentageOfWaivedExitFeesPercent
0.01
oaks Reduction To Reimbursable Expenses As Percentage Of Waived Exit Fees Percent
ReductionToReimbursableExpensesAsPercentageOfWaivedExitFeesPercent
0.01
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
52275230 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
52275230 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
52248631 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
52248631 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2400000 shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2400000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2400000 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2400000 shares
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
CY2023Q2 oaks Fair Market Value Average Closing Prices Share Of Common Stock Reported Nyse Period
FairMarketValueAverageClosingPricesShareOfCommonStockReportedNYSEPeriod
10 tradingday
CY2024Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
oaks-20240630_cal.xml Edgar Link unprocessable
0001628280-24-036809-index-headers.html Edgar Link pending
0001628280-24-036809-index.html Edgar Link pending
0001628280-24-036809.txt Edgar Link pending
0001628280-24-036809-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lft10-q20240630_ex31x1.htm Edgar Link pending
lft10-q20240630_ex31x2.htm Edgar Link pending
lft10-q20240630_ex32x1.htm Edgar Link pending
lft10-q20240630_ex32x2.htm Edgar Link pending
lft10-q20240630_ex99x1.htm Edgar Link pending
MetaLinks.json Edgar Link pending
oaks-20240630.htm Edgar Link pending
oaks-20240630.xsd Edgar Link pending
oaks-20240630_g1.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
oaks-20240630_def.xml Edgar Link unprocessable
oaks-20240630_lab.xml Edgar Link unprocessable
oaks-20240630_pre.xml Edgar Link unprocessable
oaks-20240630_htm.xml Edgar Link completed
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending